Literature DB >> 8679613

Transforming growth factor beta 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2.

A P Hinck1, S J Archer, S W Qian, A B Roberts, M B Sporn, J A Weatherbee, M L Tsang, R Lucas, B L Zhang, J Wenker, D A Torchia.   

Abstract

The three-dimensional solution structure of human transforming growth factor beta 1 (TGF-beta 1) has been determined using multinuclear magnetic resonance spectroscopy and a hybrid distance geometry/ simulated annealing algorithm. It represents one of the first examples of a mammalian protein structure that has been solved by isotopic labeling of the protein in a eukaryotic cell line and multinuclear NMR spectroscopy. The solution structure of the 25 kDa disulfide-linked TGF-beta 1 homodimer was calculated from over 3200 distance and dihedral angle restraints. The final ensemble of 33 accepted structures had no NOE or dihedral angle violations greater than 0.30 A and 5.0 degrees, respectively. The RMSD of backbone atoms for the ensemble of 33 structures relative to their mean structure was 1.1 A when all residues were used in the alignment and 0.7 A when loop regions were omitted. The solution structure of TGF-beta 1 follows two independently determined crystal structures of TGF-beta 2 (Daopin et al., 1992, 1993; Schlunegger & Grütter, 1992, 1993), providing the first opportunity to examine structural differences between the two isoforms at the molecular level. Although the structures are very similar, with an RMSD in backbone atom positions of 1.4 A when loop regions are omitted in the alignment and 1.9 A when all residues are considered, there are several notable differences in structure and flexibility which may be related to function. The clearest example of these is in the beta-turn from residues 69-72: the turn type found in the solution structure of TGF-beta 1 falls into the category of type II, whereas that present in the X-ray crystal structure of TGF-beta 2 is more consistent with a type I turn conformation. This may be of functional significance as studies using TGF-beta chimeras and deletion mutants indicate that this portion of the molecule may be important in receptor binding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679613     DOI: 10.1021/bi9604946

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.

Authors:  Thomas B Thompson; Teresa K Woodruff; Theodore S Jardetzky
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

Review 2.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

3.  Peptide ligands that use a novel binding site to target both TGF-β receptors.

Authors:  Lingyin Li; Brendan P Orner; Tao Huang; Andrew P Hinck; Laura L Kiessling
Journal:  Mol Biosyst       Date:  2010-10-04

Review 4.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

Review 5.  The complexity of TGFβ/activin signaling in regeneration.

Authors:  René Fernando Abarca-Buis; Edna Ayerim Mandujano-Tinoco; Alejandro Cabrera-Wrooman; Edgar Krötzsch
Journal:  J Cell Commun Signal       Date:  2021-01-22       Impact factor: 5.782

6.  Identification of the growth factor-binding sequence in the extracellular matrix protein MAGP-1.

Authors:  Thomas J Broekelmann; Nicholas K Bodmer; Robert P Mecham
Journal:  J Biol Chem       Date:  2020-01-27       Impact factor: 5.157

7.  First structural glimpse of CCN3 and CCN5 multifunctional signaling regulators elucidated by small angle x-ray scattering.

Authors:  Kenneth P Holbourn; Marc Malfois; K Ravi Acharya
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

8.  A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions.

Authors:  Christian Grütter; Trevor Wilkinson; Richard Turner; Sadhana Podichetty; Donna Finch; Matthew McCourt; Scott Loning; Lutz Jermutus; Markus G Grütter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

9.  Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.

Authors:  Hardik R Mody; Sau Wai Hung; Mohammad AlSaggar; Jazmine Griffin; Rajgopal Govindarajan
Journal:  Mol Cancer Res       Date:  2016-09-13       Impact factor: 5.852

10.  Effective isotope labeling of proteins in a mammalian expression system.

Authors:  Mallika Sastry; Carole A Bewley; Peter D Kwong
Journal:  Methods Enzymol       Date:  2015-10-23       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.